Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

NCT00284271 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT00284271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00284271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
Lead sponsor
University of Cologne
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2004
Completion date
Not reported
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin´s lymphoma